Results 191 to 200 of about 108,162 (245)

Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Imatinib pharmacokinetics exhibit large interindividual variability because of differences in CYP3A4 activity—the main imatinib‐metabolizing enzyme. While therapeutic drug monitoring is effective, it requires steady‐state conditions and frequent sampling.
Anna Sofie Buhl Rasmussen   +14 more
wiley   +1 more source

Evaluation of a pantoprazole and 4‐desmethylpantoprazole‐sulfate metabolic ratio as a novel CYP2C19 phenotyping method

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims CYP2C19 is one of the most important pharmacogenes, and its activity is highly variable due to factors such as genetics or drug–drug interactions. Due to the lack of an appropriate endogenous CYP2C19 biomarker, surrogate methods to assess its activity are warranted.
Julian Peter Müller   +9 more
wiley   +1 more source

Australian Rural Surgical Workforce: A Policy Analysis. [PDF]

open access: yesAust J Rural Health
Carmichael GJ   +5 more
europepmc   +1 more source

Direct healthcare costs associated with reported patient safety incidents in two tertiary hospitals in Colombia. [PDF]

open access: yesBMC Health Serv Res
Acevedo-Peña JR   +9 more
europepmc   +1 more source

MASLD Management in Spain: A Nationwide Survey of Gastroenterologists Highlighting Gaps in Risk Assessment and Primary Care Coordination. [PDF]

open access: yesJ Clin Med
Jiménez-González C   +7 more
europepmc   +1 more source

Insights on unmet needs from a survey among social media editors by EMEUNET. [PDF]

open access: yesEULAR Rheumatol Open
Gupta L   +9 more
europepmc   +1 more source

Care-Seeking Behavior, Access to Treatment, and Under- Five Mortality in Kapolowe, a Remote Rural District in DRC: Findings from a Population Based Survey prior to iCCM Strengthening with Rectal Artesunate and Amoxicillin

open access: yes
Maseko T   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy